The latest clinical practice guideline on home oxygen therapy addresses long-term and ambulatory oxygen therapy for adults with chronic obstructive pulmonary disease and interstitial lung disease and includes the most comprehensive review of the evidence of any oxygen guideline to date.
UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of the lungs.
A team of American and Canadian researchers report that while they may feel uncomfortable, there is little empirical evidence that wearing a facemask significantly diminishes lung function, even when worn during heavy exercise.
A study from researchers at Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital in Memphis showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.
Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston UTHealth).
The Pulmonary Fibrosis Foundation today announced the “Pinpoint PF” education and awareness campaign aimed at individuals with symptoms and at a higher risk for pulmonary fibrosis (PF).
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) .
Thomas S. Valley, MD, of the University of Michigan has been selected as the first-ever recipient of the ATS/CHEST Foundation Research Grant in Diversity. The focus of the research grant is clinical research that contributes to the understanding of the pathophysiology of treatment of conditions related to pulmonary, critical care, or sleep medicine that disproportionately affects underrepresented minority patient groups.
Screening with a low-dose CT scan can identify small nodules or other abnormalities in your lungs. Finding a problem at an early stage, before there are symptoms, may make it easier to treat.
Cough, fatigue and shortness of breath are all common signs of a passing virus. However, when symptoms become chronic, lasting more than three months, these could be indicative of pulmonary fibrosis (PF). The Pulmonary Fibrosis Foundation is shining a light on PF symptoms and risk factors during peak cold and flu season.
Findings from a national study published today in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19.
UCLA Health has helped drive monumental advances in the treatment of lung cancer – increasing survival rates in the nation’s leading cause of cancer deaths.
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate who live in areas where the highly infectious illness is common. Methotrexate users who also take corticosteroids or other immunosuppressant therapies are at particular risk and need adequate TB screening.
A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy. Results of the research was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX) are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies. Details of the study was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
A new University of Saskatchewan (USask) study has found that exercise performance and blood and muscle oxygen levels are not affected for healthy individuals wearing a face mask during strenuous workouts.
A new study in mice explores the effect of aging on the regenerative properties of lung cells after lung injury. The study is published in the American Journal of Physiology-Lung Cellular and Molecular Physiology. It was chosen as an APSselect article for November.
With its multidisciplinary approach to patient care, research and education, the University of Miami Sarcoidosis Program has been recognized as one of world’s leading centers for this complex multisystem disorder by the World Association of Sarcoidosis and Other Granulomatous Diseases/Foundation of Sarcoidosis Research (WASOG-FSR).
Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging. According to researchers, the virus might attack red marrow, thus being detrimental not only for erythrocytes in the bloodstream but also for the process of the formation of the new ones.
Computed tomography angiogram (CTA) scans may offer fast and early detection of COVID-19 in acute ischemic stroke (AIS) patients, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
Ali Gholamrezanezhad, MD, a clinical emergency radiologist with Keck Medicine of USC, was one of the first researchers to study COVID-19 in early 2020. Today, Gholamrezanezhad has co-authored more than 40 papers on the disease, gathering and analyzing a wide array of data and patient scans. He offers his unique insights into a virus that has infected more than 43 million people worldwide.
A video featuring Owen Shroyer originally published by Banned.video went viral on Facebook in late October. The video claims that the U.S. Centers for Disease Control and Prevention (CDC) confirmed SARS-CoV-2, the virus that causes COVID-19, was never airborne, and wearing face masks is unnecessary. This claim is false and inaccurate. The CDC never said the virus could not be airborne. Although the CDC "updated" their guidance on its website to include aerosols among the most common forms of SARS-CoV-2 transmission, experts agree that the virus can spread through water droplets, which masks can act as a physical barrier to stpp the water droplets. There is increasing evidence that suggest airborne transmission may also play a role in the spread of COVID-19.
A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the case for radiation therapy as a treatment for cancer that has begun to spread throughout the body. Findings of the SAFRON II trial (NCT01965223) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
October is Healthy Lung Month, an apt time to educate the public about the importance of protecting our lungs against mold, airborne pollutants and smoking – which put hundreds of thousands of Americans at higher risk for pulmonary fibrosis (PF).
In a major breakthrough an international team of scientists, led by the University of Bristol, has potentially identified what makes SARS-CoV-2 highly infectious and able to spread rapidly in human cells. The findings, published in Science today [20 October] describe how the virus’s ability to infect human cells can be reduced by inhibitors that block a newly discovered interaction between virus and host, demonstrating a potential anti-viral treatment.
One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.
Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.
The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.
In a new article published in Nature Communications, Moffitt Cancer Center researcher demonstrate how a deep learning model using positron emission tomography/computerized tomography radiomics can identify which non-small cell lung cancer patients may be sensitive to tyrosine kinase inhibitor treatment and those who would benefit from immune checkpoint inhibitor therapy.
Highlights from AJPH November issue.
Researchers have developed a technique that uses ultrasound to provide non-invasive assessments of pulmonary fibrosis and pulmonary edema. The technique has been shown to both quantify lung scarring and detect lung fluid in rats. A study on pulmonary edema in humans is under way.
A new review suggests “heat-not-burn” tobacco devices may threaten cardiovascular health. The review is published ahead of print in the American Journal of Physiology-Heart and Circulatory Physiology.
Researchers from the Morgridge Institute for Research, the University of Wisconsin-Madison, and Albany Medical College have identified more than 200 molecular features that strongly correlate with COVID-19 severity, offering insight into potential treatment options for those with advanced disease.
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a drug derived from a naturally occurring human protein, a new animal study suggests.
The College of American Pathologists (CAP) has appointed Alain C. Borczuk, MD, FCAP, chief of thoracic pathology and professor of pathology at Weill Cornell Medicine in New York, to serve as editor-in-chief of CAP’s peer-reviewed publication, Archives of Pathology and Laboratory Medicine.
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.
Babies born to mothers who smoked during pregnancy are more likely to suffer from impaired lung development. They are also more susceptible to developing lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).
In some patients who died with severe COVID-19 and respiratory failure, a jelly was formed in the lungs. Researchers have now established what the active agent in the jelly is and thanks to that, this new discovery can now be the key to new effective therapies. This according to a new study at Umeå University, Sweden.
New research findings contradict statements linking wearing face masks to carbon dioxide poisoning by trapping CO2. During the COVID-19 pandemic the wearing of face masks has become a highly political issue with some individuals falsely claiming that wearing face masks may be putting people’s health at risk. The study published in the Annals of the American Thoracic Society shows otherwise.
Today, the ATS Research Program announced three research grant opportunities with support from 4DMedical, a global medical technology company with a focus on lung health. With a total grant support of $150,000, each of the three $50,000 grants will fund research in asthma, chronic obstructive pulmonary disorder or COPD, and idiopathic pulmonary fibrosis or IPF.
It started on the tennis court, in 2016. A lunge for the ball, an awkward fall, and then sore ribs with subsequent backhands. At least that's what Martin Snyder thought was the cause of his pain. He was wrong. An X-ray and further imaging over the ensuing weeks revealed that the slim and fit psychotherapist, then 73, had mesothelioma, a rare cancer usually caused by asbestos exposure.
Early results of an experimental vaping study have shown significant lung injury from E-cigarette (eC) devices with nickel-chromium alloy heating elements. The findings were consistent, with or without the use of nicotine, vitamin E oil or tetrahydrocannabinol (THC), which have previously been thought to contribute to the life-threatening respiratory problem.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right